Talk:Aripiprazole: Difference between revisions

>Spinoza
Rework
>CutieKiley
Removed vandalism
 
(71 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{decree|type=notice|message=This article is for informational purposes only and is not intended as medical advice.}}
{{headerpanel|{{Approval}}}}
{{headerpanel|{{Approval}}}}
{{SummarySheet}}
{{SummarySheet}}
'''Aripiprazole''' (branded as '''Abilify''', '''Aristada''' among others) is an atypical [[psychoactive class::antipsychotic]] approved for the treatment of schizophrenia, psychosis, bipolar disorder, and along with an antidepressant to treat major depressive disorder.
{{SubstanceBox/Aripiprazole}}


{{SubstanceBox/Aripiprazole}}
'''Aripiprazole''' (branded as '''Abilify''', '''Aristada''' among others) is an atypical [[psychoactive class::antipsychotic]] approved for the treatment of schizophrenia, [[psychosis]], bipolar disorder, and along with an antidepressant to treat major depressive disorder.


== History and culture ==
==History and culture==
Aripiprazole, developed by Otsuka Pharmaceutical and marketed as Abilify among others, was first approved in Japan in 2002 and subsequently in the United States. It was a novel development in the field of atypical antipsychotics, primarily intended for schizophrenia and bipolar disorder treatment. Over time, its use expanded to include treatment of major depressive disorder and irritability in autism spectrum disorders.
Aripiprazole, developed by Otsuka Pharmaceutical and marketed as Abilify among others, was first approved in Japan in 2002 and subsequently in the United States. It was a novel development in the field of atypical [[antipsychotics]], primarily intended for schizophrenia and bipolar disorder treatment. Over time, its use expanded to include treatment of major depressive disorder and [[irritability]] in autism spectrum disorders.


== Chemistry ==
==Chemistry==
Aripiprazole is a synthetic substance of the quinolinone class and is structurally distinct from other atypical antipsychotics. Its molecular formula is C_{23}H_{27}Cl_{2}N_{3}O_{2}, and it has a unique mechanism of action as a dopamine-serotonin system stabilizer.  
Aripiprazole is a synthetic substance of the quinolinone class and is structurally distinct from other atypical antipsychotics. Its molecular formula is C<sub>23</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>, and it has a unique mechanism of action as a dopamine-serotonin system stabilizer.  


== Pharmacology ==
==Pharmacology==
Aripiprazole's primary mechanism involves acting as a partial agonist at dopamine D2 and D3 receptors and serotonin 5-HT1A receptors, while also serving as an antagonist at serotonin 5-HT2A receptors. This dual action contributes to its efficacy in treating both the positive and negative symptoms of schizophrenia. It also exhibits moderate affinity for histamine, adrenergic, and muscarinic receptors, contributing to some of its side effects.
Aripiprazole's primary mechanism involves acting as a [[agonist|partial agonist]] at [[dopamine]] D2 and D3 receptors and [[serotonin|serotonin 5-HT1A]] receptors, while also serving as an [[antagonist]] at [[serotonin|serotonin 5-HT2A]] receptors. This dual action contributes to its efficacy in treating both the positive and negative symptoms of schizophrenia. It also exhibits moderate affinity for [[histamine]], [[adrenergic]], and muscarinic receptors, contributing to some of its side effects.


== Subjective effects ==
==Subjective effects==
{{EffectStub}}
{{EffectStub}}
{{Preamble/SubjectiveEffects}}
{{Preamble/SubjectiveEffects}}
Line 26: Line 24:
* '''[[Effect::Sedation]]''' - A common effect, manifesting as general lethargy or sleepiness.
* '''[[Effect::Sedation]]''' - A common effect, manifesting as general lethargy or sleepiness.
* '''[[Effect::Weight gain]]''' - Often reported, especially with long-term use.
* '''[[Effect::Weight gain]]''' - Often reported, especially with long-term use.
* '''[[Effect::Gastrointestinal discomfort]]''' - Including nausea and constipation.
* '''[[Effect::Nausea]]'''
* '''[[Effect::Constipation]]'''
* '''[[Effect::Headache]]''' - Some users may experience mild to moderate headaches.
* '''[[Effect::Headache]]''' - Some users may experience mild to moderate headaches.
* '''[[Effect::Dizziness]]''' - Particularly when standing up quickly or moving suddenly.
* '''[[Effect::Dizziness]]''' - Particularly when standing up quickly or moving suddenly.
Line 34: Line 33:


}}
}}
{{effects/cognitive|
|{{effects/cognitive|
Cognitive effects of Aripiprazole can include:
Cognitive effects of Aripiprazole can include:


* '''[[Effect::Improved concentration]]''' - Beneficial in conditions with attention deficits.
* '''[[Effect::Focus intensification]]''' - Beneficial in conditions with attention deficits.
* '''[[Effect::Cognitive dulling]]''' - A feeling of reduced cognitive sharpness.
* '''[[Effect::Analysis suppression]]''' - A feeling of reduced cognitive sharpness.
*'''[[Effect::Thought deceleration]]'''
* '''[[Effect::Decreased hallucinations]]''' - Particularly effective in reducing auditory hallucinations in psychosis.
* '''[[Effect::Decreased hallucinations]]''' - Particularly effective in reducing auditory hallucinations in psychosis.
* '''[[Effect::Emotional stability]]''' - Helps in mood stabilization, especially in bipolar disorder.
* '''[[Effect::Emotion suppression]]''' - Helps in mood stabilization, especially in bipolar disorder.
* '''[[Effect::Anxiety reduction]]''' - Can lower general anxiety levels.
*'''[[Effect::Sleepiness]]'''
* '''[[Effect::Anxiety suppression]]''' - Can lower general anxiety levels.
* '''[[Effect::Insomnia]]''' - Difficulty falling or staying asleep in some individuals.
* '''[[Effect::Insomnia]]''' - Difficulty falling or staying asleep in some individuals.
* '''[[Effect::Memory impairment]]''' - In rare cases, may affect short-term memory.
* '''[[Effect::Memory suppression|Short-term memory suppression]]''' - In rare cases, may affect short-term memory.
 
}}
}}
{{effects/auditory|
Auditory effects are typically therapeutic in nature, reducing symptoms in those with auditory hallucinations due to mental health conditions:
* '''[[Effect::Decreased auditory hallucinations]]''' - Often effective in reducing or eliminating auditory hallucinations in schizophrenia or other psychotic disorders.
}}
}}


== Experience reports ==
==Experience reports==
There are a limited number of experience reports for Aripiprazole given its medical usage, but some can be found in the [[experience index]] and on external platforms like Erowid.
There are a limited number of experience reports for Aripiprazole given its medical usage, but some can be found in the [[experience index]] and on external platforms like Erowid.


== Toxicity and harm potential ==
==Toxicity and harm potential==
{{toxicity}}
{{toxicity}}
Although generally safe at therapeutic doses, Aripiprazole overdose can lead to severe symptoms like seizures, vomiting, and agitation. Long-term use may increase the risk of metabolic syndrome.
Although generally safe at therapeutic doses, Aripiprazole overdose can lead to severe symptoms like seizures, vomiting, and agitation. Long-term use may increase the risk of metabolic syndrome.


=== Lethal dosage ===
===Lethal dosage===
The lethal dosage of Aripiprazole is not well-established, but it is considered to have a high therapeutic index.
The lethal dosage of Aripiprazole is not well-established, but it is considered to have a high therapeutic index.


=== Tolerance and addiction potential ===
===Tolerance and addiction potential===
Aripiprazole has a low potential for abuse and addiction. Tolerance development is minimal.
Aripiprazole has a low potential for abuse and addiction. Tolerance development is minimal.


=== Dangerous interactions ===
===Dangerous interactions===
Aripiprazole should not be combined with other substances that depress the central nervous system, such as alcohol, benzodiazepines, or opioids.
Aripiprazole should not be combined with other substances that depress the central nervous system, such as alcohol, benzodiazepines, or opioids.


== Legal status ==
==Legal status==
{{LegalStub}}
{{LegalStub}}
Aripiprazole is a prescription medication in many countries. Its legal status varies, but it is generally regulated and available only with a doctor's prescription.
Aripiprazole is a prescription medication in many countries. Its legal status varies, but it is generally regulated and available only with a doctor's prescription.


== See also ==
==See also==
* [[Responsible use]]
* [[Responsible use]]


== External links ==
==External links==
* [https://en.wikipedia.org/wiki/Aripiprazole Aripiprazole (Wikipedia)]
*[https://en.wikipedia.org/wiki/Aripiprazole Aripiprazole (Wikipedia)]
* [https://www.erowid.org/pharms/aripiprazole/ Aripiprazole (Erowid Vault)]
*[https://isomerdesign.com/pihkal/explore/9511 Aripiprazole (Isomer Design)]
 
*[https://go.drugbank.com/drugs/DB01238 Aripiprazole (DrugBank)]
== Literature ==
*[https://www.drugs.com/aripiprazole.html Aripiprazole (Drugs.com)]
* APA formatted reference


== References ==
==References==
<references />
<references />
The 2016 [[NICE]] guidance for treating psychosis and schizophrenia in children and young people recommended aripiprazole as a second line treatment after [[risperidone]] for people between 15 and 17 who are having an acute exacerbation or recurrence of psychosis or schizophrenia.<ref>{{cite web |title=Psychosis and schizophrenia in children and young people: recognition and management {{!}} Guidance and guidelines {{!}} NICE |url=https://www.nice.org.uk/guidance/cg155/chapter/Recommendations |publisher=NICE |date=October 2016}}</ref> A 2014 NICE review of the depot formulation of the drug found that it might have a role in treatment as an alternative to other depot formulations of second generation antipsychotics for people who have trouble taking medication as directed or who prefer it.<ref>{{cite web |title=Schizophrenia: aripiprazole prolonged-release suspension for injection {{!}} Guidance and guidelines {{!}} NICE |url=https://www.nice.org.uk/advice/esnm39/chapter/Key-points-from-the-evidence |publisher=NICE |date=24 July 2013}}</ref>


[[Category:Psychoactive substance]][[Category:Proofread]][[Category:Approval]]
[[Category:Psychoactive substance]][[Category:Proofread]][[Category:Approval]]
Return to "Aripiprazole" page.